Ms Hope S. Freiwald > Dechert LLP > Philadelphia, United States > Lawyer Profile
Dechert LLP Offices
CIRCA CENTRE, 2929 ARCH STREET
PA 19104-2808
United States
- Firm Profile
- Go to...
Ms Hope S. Freiwald
Work Department
Litigation
Career
Hope S. Freiwald is a trial lawyer at Dechert LLP, whose practice includes a broad range of product liability, toxic tort, commercial, and consumer class action cases. Ms. Freiwald’s experience includes serving as trial and coordinating defense counsel for numerous companies faced with complex, multi-jurisdictional litigation, typically involving scientific and public health issues.
Ms. Freiwald represents clients in internal investigations and also advises companies on reducing and managing risks. In particular, she has helped clients understand and develop strategies for reducing risk related to prescription drugs and devices, asbestos and silica exposure, ground water contamination, athletic gear, luxury boats and electronics. She has worked on pre-litigation dispute resolution, including resolution of putative mass tort claims in Europe, and has advised clients appearing before government review panels.
Education
Columbia Law School, J.D., 1990; Brown University, A.B., 1986, magna cum laude
Top Tier Firm Rankings
- Environment > Environment: transactional
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds